Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126395531 | 12639553 | 1 | I | 20160727 | 20160810 | 20160810 | EXP | BR-ALVOGEN-2016-ALVOGEN-027284 | ALVOGEN | FURLAN KC, KAKIZAKI P, VALENTE NYS, PIRES MC, CHARTUNI JCN. PRIMARY CUTANEOUS ASPERGILLOSIS AND IDIOPATHIC BONE MARROW APLASIA.ANAIS BRASILEIROS DE DERMATOLOGIA. 2016; 91(3):381-383 | 9.00 | YR | M | Y | 0.00000 | 20160810 | MD | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126395531 | 12639553 | 1 | PS | VORICONAZOLE. | VORICONAZOLE | 1 | 206398 | ||||||||||||
126395531 | 12639553 | 2 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | 0 | ||||||||||||
126395531 | 12639553 | 3 | SS | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126395531 | 12639553 | 1 | Aspergillus infection |
126395531 | 12639553 | 2 | Aspergillus infection |
126395531 | 12639553 | 3 | Aspergillus infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126395531 | 12639553 | DE |
126395531 | 12639553 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126395531 | 12639553 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |